175 related articles for article (PubMed ID: 29052216)
21. Prevalence of polycystic ovary syndrome in Thai University adolescents.
Kaewnin J; Vallibhakara O; Arj-Ong Vallibhakara S; Wattanakrai P; Butsripoom B; Somsook E; Hongsanguansri S; Sophonsritsuk A
Gynecol Endocrinol; 2018 Jun; 34(6):476-480. PubMed ID: 29202617
[TBL] [Abstract][Full Text] [Related]
22. Polycystic ovary syndrome - an update.
Boyle J; Teede HJ
Aust Fam Physician; 2012 Oct; 41(10):752-6. PubMed ID: 23210095
[TBL] [Abstract][Full Text] [Related]
23. Geographical Prevalence of Polycystic Ovary Syndrome as Determined by Region and Race/Ethnicity.
Wolf WM; Wattick RA; Kinkade ON; Olfert MD
Int J Environ Res Public Health; 2018 Nov; 15(11):. PubMed ID: 30463276
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of the polycystic ovary syndrome in female residents of Chengdu, China.
Zhuang J; Liu Y; Xu L; Liu X; Zhou L; Tang L; Kang D; Guo W; He M; Yang F; Qiu D
Gynecol Obstet Invest; 2014; 77(4):217-23. PubMed ID: 24751759
[TBL] [Abstract][Full Text] [Related]
25. Contraception use and pregnancy outcomes in women with polycystic ovary syndrome: data from the Australian Longitudinal Study on Women's Health.
Joham AE; Boyle JA; Ranasinha S; Zoungas S; Teede HJ
Hum Reprod; 2014 Apr; 29(4):802-8. PubMed ID: 24549213
[TBL] [Abstract][Full Text] [Related]
26. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
[TBL] [Abstract][Full Text] [Related]
27. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria.
March WA; Moore VM; Willson KJ; Phillips DI; Norman RJ; Davies MJ
Hum Reprod; 2010 Feb; 25(2):544-51. PubMed ID: 19910321
[TBL] [Abstract][Full Text] [Related]
28. Polycystic ovary syndrome in type 2 diabetes: does it predict a more severe phenotype?
Sim SY; Chin SL; Tan JL; Brown SJ; Cussons AJ; Stuckey BG
Fertil Steril; 2016 Oct; 106(5):1258-1263. PubMed ID: 27456547
[TBL] [Abstract][Full Text] [Related]
29. Fertility management experiences of women with polycystic ovary syndrome in Australia.
Holton S; Papanikolaou V; Hammarberg K; Rowe H; Kirkman M; Jordan L; McNamee K; Bayly C; McBain J; Sinnott V; Fisher J
Eur J Contracept Reprod Health Care; 2018 Aug; 23(4):282-287. PubMed ID: 29939804
[TBL] [Abstract][Full Text] [Related]
30. Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women.
Wongwananuruk T; Panichyawat N; Indhavivadhana S; Rattanachaiyanont M; Angsuwathana S; Techatraisak K; Pratumvinit B; Sa-Nga-Areekul N
Taiwan J Obstet Gynecol; 2018 Aug; 57(4):499-506. PubMed ID: 30122568
[TBL] [Abstract][Full Text] [Related]
31. Understanding variation in prevalence estimates of polycystic ovary syndrome: a systematic review and meta-analysis.
Skiba MA; Islam RM; Bell RJ; Davis SR
Hum Reprod Update; 2018 Nov; 24(6):694-709. PubMed ID: 30059968
[TBL] [Abstract][Full Text] [Related]
32. Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS.
Carmina E; Napoli N; Longo RA; Rini GB; Lobo RA
Eur J Endocrinol; 2006 Jan; 154(1):141-5. PubMed ID: 16382003
[TBL] [Abstract][Full Text] [Related]
33. Impact of cancer treatment on risk of infertility and diminished ovarian reserve in women with polycystic ovary syndrome.
Shandley LM; Fothergill A; Spencer JB; Mertens AC; Cottrell HN; Howards PP
Fertil Steril; 2018 Mar; 109(3):516-525.e1. PubMed ID: 29428311
[TBL] [Abstract][Full Text] [Related]
34. Gestational diabetes and type 2 diabetes in reproductive-aged women with polycystic ovary syndrome.
Joham AE; Ranasinha S; Zoungas S; Moran L; Teede HJ
J Clin Endocrinol Metab; 2014 Mar; 99(3):E447-52. PubMed ID: 24081730
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities.
Figurová J; Dravecká I; Javorský M; Petríková J; Lazúrová I
Wien Klin Wochenschr; 2016 Sep; 128(17-18):641-8. PubMed ID: 25787215
[TBL] [Abstract][Full Text] [Related]
36. Polycystic ovary syndrome: a biopsychosocial understanding in young women to improve knowledge and treatment options.
Moran L; Gibson-Helm M; Teede H; Deeks A
J Psychosom Obstet Gynaecol; 2010 Mar; 31(1):24-31. PubMed ID: 20050767
[TBL] [Abstract][Full Text] [Related]
37. Beyond fertility: polycystic ovary syndrome and long-term health.
Cooney LG; Dokras A
Fertil Steril; 2018 Oct; 110(5):794-809. PubMed ID: 30316414
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of polycystic ovaries and polycystic ovary syndrome in lesbian women compared with heterosexual women.
Agrawal R; Sharma S; Bekir J; Conway G; Bailey J; Balen AH; Prelevic G
Fertil Steril; 2004 Nov; 82(5):1352-7. PubMed ID: 15533359
[TBL] [Abstract][Full Text] [Related]
39. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis.
Cooney LG; Lee I; Sammel MD; Dokras A
Hum Reprod; 2017 May; 32(5):1075-1091. PubMed ID: 28333286
[TBL] [Abstract][Full Text] [Related]
40. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
